Stéphane Nion

Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment.

Dominique Deplanque, Patrick Gelé, Olivier Pétrault et al. · PubMed · 2003 · 241 citations

Medicine, Neuroscience, Pharmacology +17

Peroxisome Proliferator-Activated Receptor-α Activation as a Mechanism of Preventive Neuroprotection Induced by Chronic Fenofibrate Treatment

Dominique Deplanque, Patrick Gelé, Olivier Pétrault et al. · Journal of Neuroscience · 2003 · 214 citations · Full text

Medicine, Neuroscience, Pharmacology +17

An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening

Maxime Culot, Stefan Lundquist, Dorothée Vanuxeem et al. · Toxicology in Vitro · 2008 · 134 citations

Pharmacy, Neuroscience, Toxicology +14

Evidence of lowest brain penetration of an antiemetic drug, metopimazine, compared to domperidone, metoclopramide and chlorpromazine, using an in vitro model of the blood–brain barrier

Pascale Jolliet, Stéphane Nion, Dorothée Vanuxeem et al. · Pharmacological Research · 2006 · 50 citations

Medicine, Pharmacokinetics, Pharmacology +13

High-density-lipoprotein subfraction 3 interaction with glycosylphosphatidylinositol-anchored proteins

Stéphane Nion, Olivier Briand, Sophie Lestavel et al. · Biochemical Journal · 1997 · 18 citations · Full text

Life Sciences, Biochemistry, Cell Biology +15